Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What's Behind Pacific Biosciences of California's Ugly Q2 Results?

TheMotleyFool

0 0

What's Behind Pacific Biosciences of California's Ugly Q2 Results?

It's been pretty much nothing but bad news from Pacific Biosciences of California (NASDAQ: PACB) (PacBio) so far in 2020. Even after rebounding from its March lows, the stock is still down more than 20% year to date.

Unfortunately, things could get worse for PacBio before they get better. The gene-sequencing systems maker announced its second-quarter results after the market closed on Monday. Here are the highlights from PacBio's Q2 update.

Image source: Getty Images.

Source Fool.com

Like: 0

PACB

Share